RT Journal Article
T1 Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.
A1 Chioncel, Ovidiu
A1 Mebazaa, Alexandre
A1 Harjola, Veli-Pekka
A1 Coats, Andrew J
A1 Piepoli, Massimo Francesco
A1 Crespo-Leiro, Maria G
A1 Laroche, Cecile
A1 Seferovic, Petar M
A1 Anker, Stefan D
A1 Ferrari, Roberto
A1 Ruschitzka, Frank
A1 Lopez-Fernandez, Silvia
A1 Miani, Daniela
A1 Filippatos, Gerasimos
A1 Maggioni, Aldo P
A1 ESC Heart Failure Long-Term Registry Investigators, 
K1 Acute heart failure
K1 Clinical profile
K1 Outcomes
AB To identify differences in clinical epidemiology, in-hospital management and 1-year outcomes among patients hospitalized for acute heart failure (AHF) and enrolled in the European Society of Cardiology Heart Failure Long-Term (ESC-HF-LT) Registry, stratified by clinical profile at admission. The ESC-HF-LT Registry is a prospective, observational study collecting hospitalization and 1-year follow-up data from 6629 AHF patients. Among AHF patients enrolled in the registry, 13.2% presented with pulmonary oedema (PO), 2.9% with cardiogenic shock (CS), 61.1% with decompensated heart failure (DHF), 4.8% with hypertensive heart failure (HT-HF), 3.5% with right heart failure (RHF) and 14.4% with AHF and associated acute coronary syndromes (ACS-HF). The 1-year mortality rate was 28.1% in PO, 54.0% in CS, 27.2% in DHF, 12.8% in HT-HF, 34.0% in RHF and 20.6% in ACS-HF patients. When patients were classified by systolic blood pressure (SBP) at initial presentation, 1-year mortality was 34.8% in patients with SBP 140 mmHg. These differences tended to diminish in the months post-discharge, and 1-year mortality for the patients who survived at least 6 months post-discharge did not vary significantly by either clinical profile or SBP classification. Rates of adverse outcomes in AHF remain high, and substantial differences have been found when patients were stratified by clinical profile or SBP. However, patients who survived at least 6 months post-discharge represent a more homogeneous group and their 1-year outcome is less influenced by clinical profile or SBP at admission.
YR 2017
FD 2017-04-30
LK http://hdl.handle.net/10668/11157
UL http://hdl.handle.net/10668/11157
LA en
DS RISalud
RD Apr 17, 2025